About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Biomarker may Help Identifying Mesenchymal Stem Cells

by Kathy Jones on June 21, 2014 at 9:23 PM
 Biomarker may Help Identifying Mesenchymal Stem Cells

A biomarker that can be used to accurately characterize the properties and function of mesenchymal stem cells (MSCs) has been identified by researchers at Children's Medical Center Research Institute at UT Southwestern (CRI).

MSCs are the focus of nearly 200 active clinical trials registered with the National Institutes of Health, targeting conditions such as bone fractures, cartilage injury, degenerative disc disease, and osteoarthritis.

Advertisement

The finding, published in the journal Cell Stem Cell on June 19, significantly advances the field of MSC biology, and if the same biomarker identified in CRI's studies with mice works in humans, the outlook for clinical trials that use MSCs will be improved by the ability to better identify and characterize the relevant cells.

"There has been an increasing amount of clinical interest in MSCs, but advances have been slow because researchers to date have been unable to identify MSCs and study their normal physiological function in the body," said Dr. Sean Morrison, Director of the Children's Research Institute, Professor of Pediatrics at UT Southwestern Medical Center, and a Howard Hughes Medical Institute Investigator. "We found that a protein known as leptin receptor can serve as a biomarker to accurately identify MSCs in adult bone marrow in vivo, and that those MSCs are the primary source of new bone formation and bone repair after injury."
Advertisement

In the course of their investigation, the CRI researchers found that leptin receptor-positive MSCs are also the main source of factors that promote the maintenance of blood-forming stem cells in the bone marrow.

"Unfortunately, many clinical trials that are testing potential therapies using MSCs have been hampered by the use of poorly characterized and impure collections of cultured cells," said Dr. Morrison, senior author of the study and holder of the Mary McDermott Cook Chair in Pediatric Genetics at UT Southwestern. "If this finding is duplicated in our studies with human MSCs, then it will improve the characterization of MSCs that are used clinically and could increase the probability of success for well-designed clinical trials using MSCs."
Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Genetics & Stem Cells News

Is Stem Cell Therapy Safe for Relapsing-Remitting Multiple Sclerosis Treatment?
Relapsing-remitting multiple sclerosis has been successfully treated using autologous hematopoietic stem cell therapy.
Genetic Insights Into Androgenetic Alopecia's
Innovative discoveries in male hair loss research uncover uncommon genetic variants tied to it.
Uncovering Genetic Harmony for Safer Hearts
Researchers achieved a significant milestone in uncovering the genetic basis of dilated cardiomyopathy in Dobermanns.
Gene Therapy Breaks Up New Dawn for Beta Thalassemia
Groundbreaking gene therapy for genetic beta thalassemia is now accessible as a treatment to a patient post-FDA approval.
Scientists Uncover Stem Cells in the Thymus for the First Time
Thymic stem cells actively participate in their environment by generating extracellular matrix proteins, essentially forming their own support system.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Biomarker may Help Identifying Mesenchymal Stem Cells Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests